These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17335002)
1. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Olatunji BO; Feldman G; Smits JA; Christian KM; Zalta AK; Pollack MH; Simon NM Depress Anxiety; 2008; 25(2):167-71. PubMed ID: 17335002 [TBL] [Abstract][Full Text] [Related]
2. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine. Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366 [TBL] [Abstract][Full Text] [Related]
3. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Razavi D; Allilaire JF; Smith M; Salimpour A; Verra M; Desclaux B; Saltel P; Piollet I; Gauvain-Piquard A; Trichard C; Cordier B; Fresco R; Guillibert E; Sechter D; Orth JP; Bouhassira M; Mesters P; Blin P Acta Psychiatr Scand; 1996 Sep; 94(3):205-10. PubMed ID: 8891089 [TBL] [Abstract][Full Text] [Related]
4. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. Silverstone PH; Salinas E J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362 [TBL] [Abstract][Full Text] [Related]
6. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514 [TBL] [Abstract][Full Text] [Related]
7. Spotlight on paroxetine in psychiatric disorders in adults. Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788 [TBL] [Abstract][Full Text] [Related]
8. Fluoxetine treatment of depressed patients with comorbid anxiety disorders. Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627 [TBL] [Abstract][Full Text] [Related]
10. [The use of antidepressants to treat depression in children and adolescents]. Desombre H; Paccalin C; Revol O; Fourneret P Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608 [No Abstract] [Full Text] [Related]
12. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. Rosenthal M J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy in depressed children and adolescents. Taurines R; Gerlach M; Warnke A; Thome J; Wewetzer C World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988 [TBL] [Abstract][Full Text] [Related]
15. The patient with comorbid depression and anxiety: the unmet need. Bakish D J Clin Psychiatry; 1999; 60 Suppl 6():20-4. PubMed ID: 10235121 [TBL] [Abstract][Full Text] [Related]
16. An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder. Schwartz TL; Nasra GS; Ashton AK; Kang D; Kumaresan H; Chilton M; Bertone F Ann Clin Psychiatry; 2007; 19(1):25-30. PubMed ID: 17453658 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880 [TBL] [Abstract][Full Text] [Related]
18. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Simon NM; Zalta AK; Worthington JJ; Hoge EA; Christian KM; Stevens JC; Pollack MH Depress Anxiety; 2006; 23(6):373-6. PubMed ID: 17068858 [TBL] [Abstract][Full Text] [Related]
19. Personality disorder scores improve with effective pharmacotherapy of depression. Black KJ; Sheline YI J Affect Disord; 1997 Mar; 43(1):11-8. PubMed ID: 9127826 [TBL] [Abstract][Full Text] [Related]
20. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. Judge R; Parry MG; Quail D; Jacobson JG Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]